Traverse 2024 Study

Traverse 2024 Study. This position paper is written in response to results of the traverse study, published in june 2023, which reported no increased risk of major adverse cardiovascular events (mace) in. Mohit khera, md, mba, mph, provides an update on the results of the landmark traverse trial, which examined the potential cardiovascular effects of testosterone therapy in men.

Explore the traverse trial led by dr. By craig manning | oct.